Volume 14, Number 2—February 2008
    
    Research
Diagnosis of Cystic Echinococcosis, Central Peruvian Highlands
Table 1
Immunoblot assay results for cystic echinococcosis, central Peruvian Highlands, using 2 immunoblot assays with different antigens*
| Community | No. samples | Antigen, no. (%) positive | 
|
|---|---|---|---|
| IBCF | rEpC1-GST | ||
| Tambochaca | 
62 | 
2 (3.2) | 
17 (27.4) | 
| Huarautambo | 
54 | 
2 (3.7) | 
10 (18.5) | 
| Astobamba | 
79 | 
5 (6.3) | 
12 (15.2) | 
| Santiago Pampa | 
213 | 
17 (8) | 
35 (16.4) | 
| 12 de Octubre | 
84 | 
11 (13.1) | 
10 (11.9) | 
| Andachaca | 
118 | 
11 (9.3) | 
25 (21.2) | 
| Uchumarca | 
113 | 
15 (13.3) | 
27 (23.9) | 
| Tambopampa | 
107 | 
10 (9.4) | 
30 (28) | 
| Ayayog | 
74 | 
6 (8.1) | 
14 (18.9) | 
| Other† | 
25 | 
4 (16) | 
3 (12) | 
| Total | 929 | 83 (8.9)‡ | 183 (19.7)‡ | 
*IBCF, antigen was bovine hydatid cyst fluid; rEpC1-GST, antigen was recombinant EpC1 glutathione S-transferase.
†Group of volunteers who came from nearby communities and were also included in the survey.
‡Statistically different (p<0.01), with higher percentage of seropositivity for rEpC1-GST than IBCF.
Page created: July 07, 2010
                            Page updated: July 07, 2010
                            Page reviewed: July 07, 2010
        
    The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.